Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Muhammad Usman Almani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Aortic Valve. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Patients with hypertrophic obstructive cardiomyopathy (HOCM) were excluded from all major trials for transcatheter aortic valve replacement (TAVR). “Suicide left ventricle” occurring after TAVR is postulated to occur as a result of chronic pressure overload from fixed obstruction that is acutely relieved after the valve deployment resulting in worsening left ventricular outflow tract obstruction.
Aims
The aim of this study was to determine the clinical and readmission outcomes in HOCM patients undergoing TAVR.
Methods
Data was extracted from the National Inpatient and National Readmission 2016−2020 Databases. We performed multivariable Logistic regression analysis to determine the odds of in‐hospital mortality and other relevant clinical outcomes in patients undergoing TAVR with and without comorbid HOCM. Multivariable Cox regression analysis was used to assess 30‐day hospital readmission in HOCM patients undergoing TAVR.
Results
We identified 296,670 patients who underwent TAVR, of whom 534 (0.2%) had comorbid HOCM. The patients undergoing TAVR with comorbid HOCM had more than threefold higher risk of in‐hospital mortality (adjusted odds ratio: 3.47, 95% CI 1.37–8.81, p = 0.009) when compared to patients without HOCM. Additionally, patients undergoing TAVR with comorbid HOCM had a higher risk of atrioventricular blocks, cardiogenic shock, acute kidney injury, and the need for intubation. There was no difference in readmission outcomes post‐TAVR among patients with and without HOCM.
Conclusion
Our analysis of a large, real‐world cohort of patients undergoing TAVR showed that patients with HOCM have a significantly higher risk of in‐hospital mortality and procedural complications when compared to patients without HOCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Internal Medicine, Nazareth Hospital, Philadelphia, Pennsylvania, USA.
- Division of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Cardiology, Yale University Hospital, New Haven, Connecticut, USA.
- Division of Medicine, Guthrie Medical Group, Cortland, New York, USA.
ORCID-Profile: Muhammad Usman Almani, Mohammad Hamza
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Almani, M. U., Ahluwalia, V., Yousuf, M., Alzubi, J., Hamza, M., Bonita, R., & Witzke, C. (2025). Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70201
Vancouver
Almani MU, Ahluwalia V, Yousuf M, Alzubi J, Hamza M, Bonita R, et al. Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70201
BibTeX
@article{Almani2025,
author = {Almani, Muhammad Usman and Ahluwalia, Vibhor and Yousuf, Muhammad and Alzubi, Jafar and Hamza, Mohammad and Bonita, Raphael and Witzke, Christian},
title = {Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70201}
}
EUVIMED